Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
Clinical trial NCT03334487 · WITHDRAWN
Trial details
- NCT number
- NCT03334487
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2018-12-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.